Current status of the treatment of HER-2 positive breast cancer

Date 05 March 2016
Event ESMO Symposium on Signalling Pathways in Cancer 2016
Session Targeting the EGFR/HER family in breast and gastric cancers
Topics Anti-Cancer Agents & Biologic Therapy
Breast Cancer
Translational Research
Presenter Javier Cortés
Authors C. Zielinski1, J. Cortés2
  • 1Department Of Medicine I And Comprehensive Cancer Center, Medical University Vienna, 1090 - Vienna/AT
  • 2Medical Oncology, Vall d'Hebron Institute of oncology, 08035 - Barcelona/ES